Table 1.
Patient characteristics.
| Patient | Age (y) | Sex | WBC/mm3 | Morphological diagnosis | Phenotype | BM blast infiltration (%) | Risk stratification | Risk factor |
|---|---|---|---|---|---|---|---|---|
| 1 | 12 | M | 87,900 | ALL-L2 | B-ALL | 88.9 | HR | Leukocytosis Age |
| 2 | 2 | F | 12300 | ALL-L1 | B-ALL | 80 | SR | — |
| 3 | 7 | M | 13800 | ALL-L1 | B-ALL | 96 | SR | — |
| 4 | 7 | F | 157,000 | ALL-L1 | B-ALL | 78.1 | HR | Leukocytosis |
| 5 | 10 | M | 70,700 | ALL-L1 | B-ALL | 80 | HR | Age Leukocytosis |
| 6 | 7 | M | 123,000 | ALL-L2 | B-ALL | 98 | HR | Leukocytosis |
| 7 | 9 | M | 25,800 | ALL-L2 | B-ALL | 98.5 | SR | — |
| 8 | 20 | F | 15,630 | ALL-L1 | B-ALL | 80 | HR | Age |
| 9 | 13 | M | 211,000 | ALL-L2 | B-ALL | 98 | HR | Age Leukocytosis |
| 10 | 4 | M | 34,220 | ALL-L1 | B-ALL | 90 | SR | — |
| 11 | 4 months | F | 156,800 | ALL-L1 | C-ALL | 94 | HR | Age Leukocytosis |
| 12 | 7 | M | 17,400 | ALL-L1 | T-ALL | 71.4 | HR | T-cell phenotype |
| 13 | 3 | M | 75,800 | ALL-L1 | T-ALL | 89 | HR | T-cell phenotype No response to initial dexamethasone treatment Leukocytosis Positive cerebrospinal fluid |
| 14 | 7 | M | 37,300 | ALL-L2 | M-ALL | 94.2 | HR | No response to initial dexamethasone treatment |
| 15 | 13 | M | 200,000 | ALL-L2 | M-ALL | 68 | HR | Age Leukocytosis |
| 16 | 15 | M | 144,600 | AML-M1 | AML | 94 | HR | Leukocytosis |
y: years old; WBC: white blood cell count; BM: bone marrow; M: male; F: female; B-ALL: B cell precursor acute lymphoblastic leukemia; T-ALL: T cell acute lymphoblastic leukemia; M-ALL: mixed acute leukemia; AML: Acute myeloid leukemia; C-ALL: congenital leukemia; HR: high risk; SR: standard risk.